Key Market Indicators
Dutch Diagnostic Reagent Sales are projected to surge to approximately €698 million by 2028, up from around €415 million in 2023. This marks an average annual growth rate of 8.1%. Notably, since the year 2000, the Dutch market has seen a significant year-on-year increase of 45.5%. In 2023, the Netherlands ranked sixth in this sector, with Denmark surpassing it at the same €415 million figure. Spain, the United Kingdom, and Finland occupied the second, third, and fourth positions, respectively. In terms of imports, Dutch Diagnostic Reagent imports are expected to reach about $2.3 billion by 2028, rising from nearly $2 billion in 2023. This represents an average annual growth rate of 2.5%. Since 1997, Dutch demand for these reagents has grown by 3.6% each year. On the export front, the Netherlands is anticipated to see its Diagnostic Reagent exports climb to roughly $3.2 billion by 2028, up from approximately $2.7 billion in 2023. This translates to an average annual growth rate of 2.5%. Since 1997, the Dutch supply has increased by 3.7% annually. In 2023, the Netherlands ranked third in exports, with Germany taking the lead at the same $2.7 billion figure. Germany, the Netherlands, and the United Kingdom held the second, third, and fourth spots, respectively, in this ranking.
